REX Health Ventures is a venture capital firm that invests in healthcare companies.

REX Health Ventures

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health. As an entrepreneur-friendly strategic investor, RHV accelerates access to new healthcare products and services to improve patient care. RHV was established by UNC REX in 2012 as part of its commitment to innovation. Leveraging the talent and subject matter experts across UNC REX and the UNC Health network, RHV partners with emerging companies throughout North Carolina and the U.S.

Bardy Diagnostics

Veran Medical Technologies

Gauss Surgical

Phynd Technologies

Rex Health Ventures

Wonderful to see Censinet's recent release of the CPG Compliance Starter Toolkit, now available for American Hospital Association members.

This toolkit is like the Swiss Army knife of compliance towards the recently-announced goals – loaded with great tools to assess, align, benchmark, implement, monitor, and comply with Essential and Enhanced CPGs.

Grateful to the American Hospital Association for the collaboration and to Ed Gaudet and the Censinet team for all their effort in making this initiative happen. Thanks for all you do to continue making our healthcare ecosystem safer from cyberthreats.

Evan Bernath, Anita Watkins, John Perez, Rex Health Ventures

#HealthcareInnovation #Cybersecurity #Compliance

Big news from Arrivo BioVentures LLC! 
 
The FDA has granted Fast Track Designation to their novel lipase inhibitor, RABI-767, for the treatment of patients with acute pancreatitis at risk of progressing to severe disease.
 
“The Fast Track Designation highlights the high unmet medical need for patients with acute pancreatitis and the importance of finding safe, effective treatments,” said Steve Butts, CEO of Arrivo BioVentures.
 
Congratulations to Steve Butts and the entire Arrivo BioVentures team for this significant milestone. Rex Health Ventures is proud to support their innovative efforts in bringing life-saving solutions to patients facing this critical disease.
 
Anita Watkins, Evan Bernath, Natasha Bonett DeLong, John Perez, UNC Health
 
#Innovation #RexHealthVentures #FDAFastTrackDesignation #AcutePancreatitis #UNCHealth #CVC

Thank you for the great conversation with Giovanni Lauricella!  Rex Health Ventures, UNC Health, UNC Health Rex, MedTech World

We are thrilled to share the latest episode of the MedTech Startup Podcast featuring our very own Anita Watkins, Managing Director at Rex Health Ventures!
 
Anita sat down with Giovanni Lauricella, Managing Partner of Lifeblood, in Malta at MedTech World to discuss the pivotal role of UNC Health and hospital venture arms in MedTech innovation. Tune in to hear Anita’s insights on:
 
- Investment strategies for MedTech startups
- The unique advantages of partnering with hospital venture arms
- Significance of clinical data and early advocates
 
Thanks, Giovanni Lauricella, for hosting a great discussion. Don’t miss this deep dive into the world of healthcare system venture investing and reach out if you’d like to get more deeply connected with the Rex Health Ventures team.
 
https://lnkd.in/gRDwFXuG
 
John Perez, Evan Bernath, Natasha Bonett DeLong
 
#MedTech #Innovation #VentureCapital #Healthcare #CVC #RexHealthVentures

Let’s keep the good news rolling – congrats to Vergent Bioscience for this great validation! 

The Annals Of Thoracic Surgery has published Phase 2 data demonstrating that Vergent Bioscience’s tumor-targeted imaging agent, VGT-309, may help surgeons visualize difficult-to-find and previously undetected tumors during minimally invasive and robotic-assisted surgeries. 

Rex Health Ventures is proud of John Santini and the entire Vergent Bioscience team for their relentless innovation and dedication to improving patient lives. 

Anita Watkins, Evan Bernath, John Perez, UNC Health

#Innovation #RexHealthVentures #TumorVisualization #LungCancer #RoboticSurgery #SurgicalAdvancements #UNCHealth #CVC

💡 Applications for GRO are now open! 💡 

GRO is a 12-week Incubator powered by CED. 

If selected, you will attend weekly classes led by subject matter experts and seasoned entrepreneurs, where you will learn how to build a scalable business. Your company will be assigned a coach and you will receive 1:1 support, collaborate, and receive feedback as you progress.
 
Apply here ▶  https://lnkd.in/g_83FgE8

#GRO #entrepreneurship #startups

REXH

COM:REXHEALTHVENTURES

REX Health Ventures